Riskpilot← Back to searchSign inGet full accessMediNord inVäst AB
ABActiveOrg 5562083039General medical practice activities · NACE 8621Est. 19810 employees
Revenue 2024
SEK 12,5M
+15% vs 2023
EBITDA margin
58.1%
+180% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
SEK 4,4M
+93% vs 2023
| Revenue | SEK 12,5M | +15% |
| EBITDA | SEK 7,3M | +180% |
| Net profit | SEK 4,4M | +93% |
| Total assets | SEK 14,5M | +85% |
| Equity | SEK 10,2M | +63% |
| Employees | 0 | — |
Legal name
MediNord inVäst AB
Org number
5562083039
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
26 januari 1981
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva privat läkarverksamhet i egen regi och på kosultbasis, undervisning och informationsverksamhet inom det medicinska området, handel med lös egendom inom det medicinska området, handel med och förvaltning av värdepapper och fastig- heter samt därmed förenlig verksamhet.
Address
Email
medinord@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 587 | 6 209 | 5 730 | 10 874 | 12 475 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −526 | 1 102 | 224 | 2 589 | 7 251 |
| Depreciation & amort. | −38 | −34 | −34 | −81 | −34 |
| EBIT | −564 | 1 068 | 190 | 2 508 | 7 217 |
| Net financials | −1 | — | — | 4 | 2 |
| Profit before tax | −305 | 1 487 | 360 | 2 862 | 5 519 |
| Tax | −0 | −257 | −80 | −597 | −1 139 |
| Net profit | −305 | 1 230 | 280 | 2 265 | 4 380 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 671 | 6 218 | 5 846 | 7 872 | 14 540 |
| Equity | 3 566 | 4 575 | 4 417 | 6 261 | 10 188 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 870 | 828 | 784 | 1 315 | 2 357 |
| Total debt | 870 | 828 | 784 | 1 315 | 2 357 |
EBITDA margin
58.1%
This company
15.8%
Market median
+268% vs market
20202024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
43.0%
This company
18.4%
Market median
+134% vs market
20202024
Net profit margin
35.1%
This company
8.1%
Market median
+333% vs market
20202024
Asset turnover
0.86×
This company
1.12×
Market median
+23% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OS Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MediNord inVäst AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olof Sören Maxén | Audit | 0 companies |
| Gun Anita Nordenson | Deputy Board Member | 0 companies |
| Ulf Jörgen Nordenson | Board of Directors | 0 companies |